Skip to content

MMGH Consulting (Switzerland)

MMGH Consulting is a Swiss independent advisory firm that helps public and non-profit clients improve access to vaccines and disease control programmes worldwide.

Last updated September 29, 2026

AI crawler reads

No AI crawler has read this profile since Oct 28, 2026.

Overview

MMGH Consulting (also known as MM Global Health Consulting) is an independent, science-driven advisory firm headquartered in Zurich, Switzerland, with a second office in Versoix. Founded in 2017 by Stefano Malvolti and Carsten Mantel, the firm works to improve access to vaccination and disease control programmes by supporting public and non-profit clients in developing, implementing and evaluating evidence-based policies, strategies, products and tools. Its stated mission is to contribute to a world free from vaccine-preventable and neglected tropical diseases. The firm organises its work across four interconnected pillars: Access, Policy & Strategy, Implementation, and Evaluation. Under Access, MMGH helps vaccines reach people in low- and middle-income countries, spanning the full pathway from early product development to implementation readiness, including value and investment cases, market readiness assessments, pathway design and stakeholder engagement. Policy & Strategy supports partners in developing clear, evidence-based strategies and policies for decision-making, from product prioritisation to global investment planning. Implementation translates global strategies into real-world action with countries, partners and global institutions. Evaluation delivers assessments that generate actionable insights and enable continuous learning. MMGH draws on a worldwide network of experts with public health, implementation and academic backgrounds, assembling a tailored team for each project. The firm reports having worked with clients including the World Health Organization (WHO), Gavi, the Vaccine Alliance, and UNICEF, completing more than 100 projects in 27 countries. Its team members are based in four cities, with clients in 16 cities and research conducted in 27 countries. The firm publishes reports and analyses on topics such as heat-stable vaccines and vaccine innovation prioritisation. As a private company, MMGH Consulting GmbH is not publicly listed. It positions itself as an independent, unbiased advisor focused on global health, particularly immunisation and neglected tropical diseases, and maintains a presence on LinkedIn for updates.

History

MMGH Consulting was founded in 2017 by Stefano Malvolti and Carsten Mantel as an advisory firm intended to translate scientific evidence, data and knowledge into strategies and actions directly impacting people's health and bringing the world closer to vaccine equality. The firm is headquartered in Zurich, Switzerland, with a branch office in Versoix, Switzerland. From its inception, MMGH focused on supporting public and non-profit clients in improving the implementation and evaluation of vaccine programmes and products. Its work is organised across four interconnected pillars: Access, Policy & Strategy, Implementation, and Evaluation. Under Access, the firm helps vaccines reach people in low- and middle-income countries, spanning the full pathway from early product development to implementation readiness. Policy & Strategy supports partners in developing evidence-based strategies and policies for decision-making. Implementation translates global strategies into real-world action with countries, partners and global institutions. Evaluation delivers assessments that generate actionable insights and enable continuous learning. The firm reports having worked with clients including the World Health Organization (WHO), Gavi, the Vaccine Alliance, and UNICEF, completing more than 100 projects in 27 countries. Its team members are based in four cities, with clients in 16 cities and research conducted in 27 countries. MMGH publishes reports and analyses on topics such as heat-stable vaccines and vaccine innovation prioritisation, and maintains a presence on LinkedIn for updates. As a private company, MMGH Consulting GmbH is not publicly listed. It positions itself as an independent, unbiased advisor focused on global health, particularly immunisation and neglected tropical diseases.

  • 2026

    Published report 'Advancing heat-stable vaccines: Vaccine Innovation Prioritisation Strategy (VIPS)'.

  • 2017

    MMGH Consulting founded by Stefano Malvolti and Carsten Mantel.

  • Completed more than 100 projects in 27 countries.

Products and positioning

Independent, science-driven advisory translating evidence into strategies and actions for global health, with a focus on vaccine access and disease control.

  • Access services

    Helping vaccines reach people in low- and middle-income countries, from early product development to implementation readiness.

  • Policy & Strategy services

    Supporting partners in developing evidence-based strategies and policies for decision-making.

  • Implementation services

    Translating global strategies into real-world action with countries, partners and global institutions.

  • Evaluation services

    Delivering evaluations that generate actionable insights and enable continuous learning.

Sources5 sources

Cite this profile: Cite the canonical profile. /brand-wiki/mmgh-consulting-switzerland · Editorial policy · How profiles are compiled